What is the equity of Bioton this year?
Bioton has equity of 606.36 M PLN this year.
Bioton Equity 2024
Bioton Equity
606.36 M PLN
Ticker
BIO.WA
ISIN
PLBIOTN00029
WKN
A0D9SD
In 2024, Bioton's equity was 606.36 M PLN, a 0.37% increase from the 604.14 M PLN equity in the previous year.
Bioton Aktienanalyse
What does Bioton do?
Bioton SA is a leading Polish biotechnology company specializing in the development of innovative drugs, diagnostics, and medical devices. The company was founded in 1989 and has since achieved remarkable success. Bioton is headquartered in Poland and employs approximately 1000 people worldwide. The company is listed on the Warsaw Stock Exchange and is supported by renowned investors. Business model Bioton operates various business divisions, including research and development, production, sales, as well as marketing and distribution. The company collaborates closely with leading academic institutions and research organizations and invests significant resources in the development of new groundbreaking technologies and products. The company's products and services are distributed and used in over 60 countries worldwide. Divisions Bioton is divided into three main business sectors, including biopharmaceuticals, diagnostics, and medical devices. Biopharmaceuticals Bioton is known for its biopharmaceuticals, particularly insulin and insulin analogs. Insulin is a hormone produced by the body to regulate blood sugar levels. Bioton offers various insulin products, including human insulin, insulin glargine, and insulin aspart. These products are approved for the treatment of diabetes mellitus and are distributed in over 50 countries worldwide. Diagnostics Bioton is also involved in the development and production of diagnostics. The company offers various testing systems for the diagnosis of infectious diseases, allergies, and autoimmune diseases. The product line also includes in vitro diagnostics that are used for medical therapy monitoring and disease detection. Medical devices Bioton also manufactures and distributes medical devices such as insulin pumps and blood glucose meters. These devices are designed for people with diabetes and assist in accurate insulin dosing and blood sugar level monitoring. Products In addition to insulin and insulin analogs, Bioton also produces a wide range of other drugs, including growth hormones, as well as follicle-stimulating hormone (FSH) and luteinizing hormone (LH). These hormones are used for the treatment of infertility. Bioton is also involved in the development of novel technologies such as RNA interference (RNAi) and genomic research. The company invests significantly in innovative research projects aimed at the development of groundbreaking drugs and therapies. In conclusion, Bioton SA is a highly innovative biotechnology company with a wide range of products and a focus on research and development. The company operates in the global market and collaborates closely with renowned institutions and research organizations. Bioton's business model is based on the development of innovative technologies and products aimed at improving the quality of life for people worldwide. Bioton ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Bioton's Equity
Bioton's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Bioton's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Bioton's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Bioton's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Bioton’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Bioton stock
What was the equity of Bioton compared to the previous year?
The equity of Bioton has increased/decreased by 0.37% increased compared to the previous year.
What impact does a high equity have on investors of Bioton?
A high equity is advantageous for investors of Bioton as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Bioton?
A low equity can be a risk for investors of Bioton, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Bioton affect the company?
An increase in equity of Bioton can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Bioton affect the company?
A reduction in equity of Bioton can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Bioton?
Some factors that can affect the equity of Bioton include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Bioton so important for investors?
The equity of Bioton is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Bioton take to change the equity?
To change equity, Bioton can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Bioton pay?
Over the past 12 months, Bioton paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Bioton is expected to pay a dividend of 0 PLN.
What is the dividend yield of Bioton?
The current dividend yield of Bioton is .
When does Bioton pay dividends?
Bioton pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Bioton?
Bioton paid dividends every year for the past 0 years.
What is the dividend of Bioton?
For the upcoming 12 months, dividends amounting to 0 PLN are expected. This corresponds to a dividend yield of 0 %.
In which sector is Bioton located?
Bioton is assigned to the 'Health' sector.
Wann musste ich die Aktien von Bioton kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Bioton from 9/9/2024 amounting to 0 PLN, you needed to have the stock in your portfolio before the ex-date on 9/9/2024.
When did Bioton pay the last dividend?
The last dividend was paid out on 9/9/2024.
What was the dividend of Bioton in the year 2023?
In the year 2023, Bioton distributed 0 PLN as dividends.
In which currency does Bioton pay out the dividend?
The dividends of Bioton are distributed in PLN.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Bioton
Our stock analysis for Bioton Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bioton Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
